Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Anticancer Research|April 9, 2013
Advances in esophageal surgery in elderly patients with thoracic esophageal cancerMasaru Morita, Hajime Otsu, Hiroyuki Kawano, et al.
Clinical Breast Cancer|July 22, 2015
Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast CancerNami Yamashita, Eriko Tokunaga, Hiroyuki Kitao, et al.
Molecular Cancer Therapeutics|July 26, 2015
The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate BiosynthesisShinichi Kiyonari, Makoto Iimori, Kazuaki Matsuoka, et al.
Breast Cancer (Tokyo, Japan)|September 29, 2022
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapyShozo Ohsumi, Reiki Nishimura, Norikazu Masuda, et al.
Annals of Surgical Oncology|January 7, 2014
Technical improvement of total pharyngo-laryngo-esophagectomy for esophageal cancer and head and neck cancerMasaru Morita, Hiroshi Saeki, Shuhei Ito, et al.
Journal of Cancer Research and Clinical Oncology|October 17, 2007
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancersYasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
Breast Cancer (Tokyo, Japan)|October 8, 2024
Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trialEriko Tokunaga, Hiroji Iwata, Mitsuya Itoh, et al.
Cancer Letters|February 19, 2008
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancersYasuo Miyoshi, Masafumi Kurosumi, Junichi Kurebayashi, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2024
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatmentYutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, et al.
Breast Cancer (Tokyo, Japan)|February 18, 2021
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort studyKiyo Tanaka, Norikazu Masuda, Naoki Hayashi, et al.
Pageof 16